Arrowhead Pharmaceuticals... (ARWR)
NASDAQ: ARWR
· Real-Time Price · USD
20.50
1.72 (9.16%)
At close: Aug 15, 2025, 3:59 PM
20.90
1.93%
After-hours: Aug 15, 2025, 07:44 PM EDT
Arrowhead Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Revenue | 27.77M | 542.71M | 2.5M | 23.59M | n/a | n/a | 3.55M | 16.1M | 15.82M | 146.27M | 62.55M | 31.57M | 32.41M | 151.81M | 27.44M | 38.28M | 45.89M | 32.81M | 21.3M |
Cost of Revenue | 6.22M | 6.08M | 5.24M | 13.57M | 4.78M | 4.53M | 4.26M | 3.86M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 21.54M | 542.71M | 2.5M | 10.02M | -4.78M | -4.53M | 3.55M | 12.24M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -165.55M | 381.2M | -161.41M | -162.2M | -176.14M | -126.19M | -136.54M | -108.33M | -102.7M | 48.16M | -42.13M | -83.83M | -72.91M | 41.55M | -63.32M | -64.88M | -31.87M | -28.23M | -24.05M |
Interest Income | 11.02M | 9.62M | 7.6M | 7.17M | 6.5M | 6.25M | 2.8M | 3.88M | 4.17M | 4.56M | 2.68M | 1.58M | 1.24M | 1.05M | 1.16M | n/a | n/a | n/a | 2.17M |
Pretax Income | -175.68M | 369.62M | -175.12M | -172.8M | -173.98M | -127M | -138.69M | -108.99M | -103.38M | 47.68M | -41.79M | -82.16M | -72.05M | 44.37M | -62.87M | -63.37M | -29.92M | -26.82M | -20.73M |
Net Income | -175.24M | 370.44M | -173.09M | -170.54M | -170.79M | -125.3M | -132.86M | -109.68M | -102.95M | 48.67M | -41.33M | -85.51M | -72.05M | 44.37M | -62.87M | -63.37M | -29.92M | -26.82M | -20.73M |
Selling & General & Admin | 30.95M | 27.89M | 26.4M | 25.79M | 23.2M | 24.64M | 23.19M | 24.17M | 23.37M | 22.82M | 20.58M | 31.62M | 32.74M | 33.86M | 24.59M | 38.29M | 17.86M | 16.19M | 8.65M |
Research & Development | 162.37M | 133.1M | 137M | 135.83M | 152.43M | 101.12M | 116.49M | 99.86M | 94.76M | 74.88M | 83.69M | 83.38M | 72.18M | 75.98M | 65.77M | 65.77M | 59.33M | 44.7M | 36.55M |
Other Expenses | -6.22M | 511K | 509K | 591K | 513K | 425K | 412K | 405K | 404K | 405K | 403K | 404K | 403K | 404K | 403K | -887K | 577K | 156K | 154K |
Operating Expenses | 187.09M | 161.51M | 163.91M | 162.2M | 176.14M | 126.19M | 140.1M | 124.43M | 118.53M | 98.1M | 104.68M | 115.41M | 105.32M | 110.25M | 90.76M | 103.17M | 77.76M | 61.04M | 45.36M |
Interest Expense | 24.38M | 21.64M | 21.65M | 14.65M | 5.09M | 7.24M | 5.37M | 5.26M | 5.16M | 5.06M | 2.85M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 193.32M | 161.51M | 163.91M | 162.2M | 176.14M | 126.19M | 140.1M | 124.43M | 118.53M | 98.1M | 104.68M | 115.41M | 105.32M | 110.25M | 90.76M | 103.17M | 77.76M | 61.04M | 45.36M |
Income Tax Expense | -437K | 1.75M | 103K | 546K | n/a | n/a | -3.31M | 2.02M | 742K | n/a | 17K | 3.79M | n/a | n/a | n/a | 2K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 139.04M | 133.36M | 124.85M | 121.99M | 124.2M | 123.28M | 107.42M | 107.31M | 107M | 106.76M | 106.04M | 105.75M | 105.75M | 105.55M | 104.53M | 104.27M | 103.19M | 103.15M | 102.76M |
Shares Outstanding (Diluted) | 139.04M | 134.48M | 124.85M | 121.99M | 124.2M | 123.28M | 107.42M | 107.31M | 107M | 108.14M | 106.04M | 105.75M | 105.75M | 107.93M | 104.53M | 104.53M | 104.1M | 103.87M | 102.76M |
EPS (Basic) | -1.26 | 2.78 | -1.39 | -1.4 | -1.38 | -1.02 | -1.24 | -1.02 | -0.96 | 0.46 | -0.39 | -0.81 | -0.67 | 0.42 | -0.6 | -0.61 | -0.29 | -0.26 | -0.2 |
EPS (Diluted) | -1.26 | 2.75 | -1.39 | -1.4 | -1.38 | -1.02 | -1.24 | -1.02 | -0.96 | 0.45 | -0.39 | -0.81 | -0.67 | 0.41 | -0.6 | -0.61 | -0.29 | -0.26 | -0.2 |
EBITDA | -165.55M | 397.34M | -148.23M | -153.13M | -164.1M | -115.23M | -129.06M | -99.87M | -94.95M | 55.4M | -36.26M | -81.17M | -69.45M | 46.96M | -60.75M | -62.38M | -29.87M | -26.31M | -22.21M |
EBIT | -154.71M | 391.25M | -153.47M | -158.15M | -168.88M | -119.75M | -133.32M | -103.73M | -98.22M | 52.73M | -38.95M | -83.83M | -72.05M | 44.37M | -63.32M | -64.88M | -31.87M | -28.23M | -24.05M |
Depreciation & Amortization | 6.22M | 6.08M | 5.24M | 5.03M | 4.78M | 4.53M | 4.26M | 3.86M | 3.28M | 2.67M | 2.69M | 2.66M | 2.59M | 2.59M | 2.57M | 2.5M | 2M | 1.92M | 1.85M |